Pure Global

Gestrinone and Endothelial Function in Young Women - Trial NCT06402344

Access comprehensive clinical trial information for NCT06402344 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital Israelita Albert Einstein and is currently Recruiting. The study focuses on Hormones; Abuse,Cardiovascular Diseases. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06402344
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06402344
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Gestrinone and Endothelial Function in Young Women
Association of Hormonal Implant With Gestrinone on Endothelial Function in Young Women

Study Focus

Hormonal implant

Observational

other

Sponsor & Location

Hospital Israelita Albert Einstein

São Paulo, Brazil

Timeline & Enrollment

N/A

May 27, 2024

Dec 30, 2025

90 participants

Primary Outcome

Endothelial function

Summary

The purpose of this study is to assess the association of misuse of hormonal implant with
 gestrinone in cardiovascular health outcomes in young women.

ICD-10 Classifications

Other endocrine disorders
Other postprocedural endocrine and metabolic disorders
Other specified endocrine disorders
Other cardiovascular disorders originating in the perinatal period
Other adrenogenital disorders

Data Source

ClinicalTrials.gov

NCT06402344

Non-Device Trial